UroGen Pharma Ltd (NASDAQ:URGN) concluded the trading at $4.92 on Wednesday, June 04 with a fall of -1.60% from its closing price on previous day. Considering stock’s 52-week price range provides that URGN hit a high price of $20.70 and saw its price falling to
UroGen Pharma Ltd (NASDAQ:URGN) traded at $4.24 at close of the session on Friday, May 30 and made an upward move of 6.80% on its previous day’s price. UroGen Pharma Ltd has a market cap of $195.50 million and is expected to release its quarterly
The trading price of UroGen Pharma Ltd (NASDAQ:URGN) closed lower on Tuesday, May 27, and closing at $3.93, -6.21% lower than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $20.70 and a 52-week low
UroGen Pharma Ltd (NASDAQ:URGN) price on Wednesday, May 21, fall -44.69% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $4.17. A look at the stock’s price movement, the close in the last trading session was $7.54. Turning
UroGen Pharma Ltd (NASDAQ:URGN) price closed lower on Friday, May 16, and dropping -25.79% below its previous close. A look at the daily price movement shows that the last close reads $9.85. Taking into account the 52-week price action we note that the stock hit
UroGen Pharma Ltd (NASDAQ:URGN) shares, rose in value on Friday, May 09, with the stock price down by -2.72% to the previous day’s close as strong demand from buyers drove the stock to $10.38. Actively observing the price movement in the last trading, the stock
UroGen Pharma Ltd (NASDAQ:URGN) price closed higher on Monday, April 28, and jumping 14.08% above its previous close. A look at the daily price movement shows that the last close reads $9.87, with intraday deals fluctuated between $10.0501 and $11.68. The company’s 5Y monthly beta
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.